Schizophrenia News and Research

Latest Schizophrenia News and Research

Aestus commences ATx08-001 phase 2 trial to evaluate efficacy of novel pain therapeutic

Aestus Therapeutics, Inc., announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.

23 Feb 2011

Brain reward center responds to good and bad experiences

The so-called reward center of the brain may need a new name, say scientists who have shown it responds to good and bad experiences. The finding, published in PLoS One, may help explain the "thrill" of thrill-seeking behavior or maybe just the thrill of surviving it, according to scientists at Georgia Health Sciences University and East China Normal University.

23 Feb 2011

UCI study details benefits of physical activity, diet, relationships, fun and spirituality

Getting more exercise, spending time outdoors and helping others are among the activities that can be as effective as drugs or counseling in treating an array of mental illnesses, including depression and anxiety, according to a UC Irvine study.

23 Feb 2011

Noninvasive test to evaluate risk of ASD in infants

A computational physicist and a cognitive neuroscientist at Children's Hospital Boston have come up with the beginnings of a noninvasive test to evaluate an infant's autism risk.

22 Feb 2011

Energy drink induced psychosis in mentally ill

A new study that has appeared in the latest publication of the Medical Journal of Australia has shown that the mentally ill should avoid energy drinks as they may result in a trigger of psychosis.

21 Feb 2011

Research cuts could mean ongoing cancer deaths

In a guest column for the New Jersey Star-Ledger, a former White House spokesman and Chief-of-Staff for the House Aging Committee and Health Subcommittee, Robert Weiner, a George Washington University breast cancer laboratory director and professor, Dr. Patricia Berg, and policy analyst, James Lewis assert that "as the government keeps funding two wars and ongoing tax breaks, curing diseases like cancer is being threatened in the budget debates underway.

19 Feb 2011

Scientists find working memory highly dependent on fast inhibitory cells

Usually, we associate rhythms with dance and music. But they also play an important role in the brain. When billions of neurons communicate with each other, certain rhythmic activity patterns arise. The proper metre in this interplay is provided by nerve cells that do not excite other cells, but inhibit their activity instead. One type of these inhibiting cells acts in a particularly fast and efficient way and is therefore thought to be crucial for memory formation and information processing in neuronal networks.

18 Feb 2011

Scientists discover axons can send signals to cell body

Neurons are complicated, but the basic functional concept is that synapses transmit electrical signals to the dendrites and cell body, and axons carry signals away.

18 Feb 2011

University of Melbourne becomes first University to head Secretariat of Movement for Global Mental Health

The University of Melbourne's Centre for International Mental Health is leading the way in addressing a desperately needed and often overlooked area of aid: mental health, by becoming the first University to head the Secretariat of the Movement for Global Mental Health.

17 Feb 2011

PsychoGenics establishes alliance with KineMed to provide specialized neurogenesis services

PsychoGenics today announced the establishment of an alliance with KineMed, to provide specialized neurogenesis services to complement PsychoGenics' in vivo testing capabilities.

15 Feb 2011

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

Neuralstem, Inc. updated the progress of its ongoing Phase I human clinical trial of the company's spinal cord stem cells in the treatment of ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia.

11 Feb 2011

State roundup: Arizona Medicaid waiver; Mass. BCBS plans charge more for high-cost hospitals; Texas Dems' abortion fight

Arizona Governor Jan Brewer's proposal to cut 280,000 people from the state's Medicaid rolls is being reviewed by U.S. officials who don't know whether they have the power to approve the action, Health and Human Services Secretary Kathleen Sebelius said.

10 Feb 2011

Rhabdomyolysis episode at University of Iowa signals a public health crisis

On January 26, 2011, it was reported that 13 University of Iowa football players were affected so severely by rhabdomyolysis that they were hospitalized. Occurrences of rhabdomyolysis—muscle breakdown—are so rare that it suggests an additional causal factor, such as a drug.

10 Feb 2011

Study unveils surprising mechanism that controls brain formation

A study from The Scripps Research Institute has unveiled a surprising mechanism that controls brain formation. The findings have implications for understanding a host of diseases, including some forms of mental retardation, epilepsy, schizophrenia, and autism.

10 Feb 2011

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Neuralstem, Inc. announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients.

10 Feb 2011

Johns Hopkins funds 12 research groups to launch new BSi program on cognitive disorders

The Johns Hopkins Brain Sciences Institute has funded a total of $5 million to 12 different research groups at Hopkins to launch the new Synapses, Circuits and Cognitive Disorders Program. The new BSi program aims to understand the fundamentals of brain function by focusing on the synapse — the point of contact between two nerve cells — to better understand cognitive disorders.

9 Feb 2011

New study: Cannabis use significantly hastens onset of psychotic illness

A new study has provided the first conclusive evidence that cannabis use significantly hastens the onset of psychotic illnesses during the critical years of brain development - with possible life-long consequences.

9 Feb 2011

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

Metabolon, the leader in metabolomics, biomarker discovery and analysis, announced today the grant of US Patent No. 7,884,318 entitled "Systems, Methods, and Computer-Readable Medium for Determining Composition of Chemical Constituents in a Complex Mixture".

8 Feb 2011

Cannabis use accelerates psychosis in the young: Study

A new study has shown that cannabis use can hasten the onset of schizophrenia by several years. The study included data from 20,000 patients with a psychotic illness and found those who smoked cannabis were diagnosed almost three years ahead of those who did not use the drug. The research is published in the journal Archives of General Psychiatry.

8 Feb 2011

Elan 2010 total revenue increases 5% to $1,169.7 million

Elan Corporation, plc today reported its fourth quarter and full-year 2010 financial results and provided financial guidance for 2011.

8 Feb 2011

Schizophrenia News and Research

Latest Schizophrenia News and Research

Aestus commences ATx08-001 phase 2 trial to evaluate efficacy of novel pain therapeutic

Brain reward center responds to good and bad experiences

UCI study details benefits of physical activity, diet, relationships, fun and spirituality

Noninvasive test to evaluate risk of ASD in infants

Energy drink induced psychosis in mentally ill

Research cuts could mean ongoing cancer deaths

Scientists find working memory highly dependent on fast inhibitory cells

Scientists discover axons can send signals to cell body

University of Melbourne becomes first University to head Secretariat of Movement for Global Mental Health

PsychoGenics establishes alliance with KineMed to provide specialized neurogenesis services

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

State roundup: Arizona Medicaid waiver; Mass. BCBS plans charge more for high-cost hospitals; Texas Dems' abortion fight

Rhabdomyolysis episode at University of Iowa signals a public health crisis

Study unveils surprising mechanism that controls brain formation

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Johns Hopkins funds 12 research groups to launch new BSi program on cognitive disorders

New study: Cannabis use significantly hastens onset of psychotic illness

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

Cannabis use accelerates psychosis in the young: Study

Elan 2010 total revenue increases 5% to $1,169.7 million

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Schizophrenia News and Research

Latest Schizophrenia News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in